In this episode, host McCall McPherson discusses a breakthrough in testosterone therapy with Shalin Shah, CEO of Marius Pharmaceuticals. They explore the development and benefits of Kyzatrex, a new oral testosterone replacement therapy. Shalin shares his journey into the testosterone space and highlights the importance of testosterone for overall health. They address the prevalence of low testosterone, its symptoms, and the limitations of traditional therapies. Kyzatrex offers a safer, more effective alternative with stable hormone levels and fewer side effects. The episode emphasizes the need for increased awareness and research in testosterone health.
Links and Resources:
Modern Thyroid and Wellness